Dengue fever is far more than just a common cold; it can be severe and even life-threatening. Fortunately, medical innovation has introduced a vital solution: the QDENGA Dengue Vaccine. This vaccine significantly reduces health risks and provides peace of mind for every member of your family.
Dengue fever is caused by the dengue virus, transmitted through the bite of an infected Aedes mosquito. Common symptoms include:
Sudden high fever (38-40°C) lasting 2-7 days.
Severe headache, pain behind the eyes, or muscle and joint aches.
Skin rash or small red spots (petechiae).
Nausea, vomiting, and loss of appetite.
QDENGA is an internationally recognized dengue vaccine. It offers several key advantages over previous generations:
Broad Eligibility: Suitable for individuals aged 4 to 60 years.
No Blood Test Required: Can be administered immediately without needing a prior screening for past dengue infection.
Comprehensive Protection: Effective against all four serotypes of the dengue virus (1, 2, 3, and 4).
Reduced Severity: Proven to reduce hospitalization rates by 90.4% and prevent symptomatic infection by 80.2%.
Dosage: 2 doses.
Interval: 3 months apart.
Age Group: 4 - 60 years old.
Prevention is always better than cure. The QDENGA vaccine does more than just protect you from infection; it reduces the burden of medical expenses and shields you from life-threatening complications, such as dengue shock syndrome, heart failure, and liver or kidney failure.
Two doses of the QDENGA dengue vaccine.
The promotional period runs from February 1st to June 30th, 2026.
For more information, please contact
Lifestyle Health Screening Center, G Floor, Building 2. Tel. 02-561-1111 ext. 2110-2111
Privacy Policy | Cookie Policy
Copyright © Vibhavadi Hospital. All right reserved